Skip to main content

Clinical trial The APOLLO Study

A phase III Study comparing Pomalidomide and Dexamethasone with or without Daratumumab in Subjects with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy with both Lenalidomide and a Proteasome Inhibitor

Cancers
Organ Myeloma
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor EMN
EudraCT Identifier 2017-001618-27
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03180736
Inclusion criteria - prior anti-myeloma treatment included both a PI- and lenalidomide-containing regimens- no previous therapy with Pomalidomide nor CD-38 MoAb
Last update